Jane Street’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Hold |
0
| – | – | – | 6283 |
|
2025
Q1 | – | Sell |
-77,869
| Closed | -$632K | – | 6337 |
|
2024
Q4 | $632K | Buy |
77,869
+50,027
| +180% | +$406K | ﹤0.01% | 3599 |
|
2024
Q3 | $503K | Sell |
27,842
-28,006
| -50% | -$506K | ﹤0.01% | 4275 |
|
2024
Q2 | $575K | Buy |
55,848
+30,827
| +123% | +$318K | ﹤0.01% | 4364 |
|
2024
Q1 | $266K | Sell |
25,021
-40,233
| -62% | -$427K | ﹤0.01% | 4739 |
|
2023
Q4 | $596K | Sell |
65,254
-5,530
| -8% | -$50.5K | ﹤0.01% | 3915 |
|
2023
Q3 | $734K | Buy |
70,784
+59,584
| +532% | +$618K | ﹤0.01% | 3201 |
|
2023
Q2 | $160K | Sell |
11,200
-2,145
| -16% | -$30.7K | ﹤0.01% | 4646 |
|
2023
Q1 | $95.3K | Sell |
13,345
-7,338
| -35% | -$52.4K | ﹤0.01% | 4972 |
|
2022
Q4 | $232K | Sell |
20,683
-10,886
| -34% | -$122K | ﹤0.01% | 4246 |
|
2022
Q3 | $350K | Buy |
+31,569
| New | +$350K | ﹤0.01% | 4029 |
|
2021
Q2 | – | Sell |
-8,193
| Closed | -$308K | – | 5615 |
|
2021
Q1 | $308K | Buy |
+8,193
| New | +$308K | ﹤0.01% | 3893 |
|